Lv2
164 积分 2022-08-08 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1天前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
1天前
已完结
中国乳腺癌抗体药物偶联物安全性管理专家共识
7天前
已完结
中国乳腺癌PIK3CA基因突变检测专家共识（2025版）
11天前
已完结
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer
12天前
已完结
Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkers
13天前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer
13天前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
13天前
已完结
乳腺癌HER2检测指南（2024版）
15天前
已完结
皖公网安备34019202002308
